Loading…
Based on limited metadata, the FDA issued a Warning Letter to Daito Kasei Kogyo Co Ltd on January 18, 2018, regarding an unspecified product category classified as "Other." Without access to the full letter text or detailed subject information, the specific nature of the regulatory violations cannot be determined from the available metadata. The issuing office is also not documented in the metadata provided. This summary should be supplemented with the complete Warning Letter text to identify the actual compliance issues and regulatory requirements involved.